search
Back to results

Analgesia in Lingual Frenulotomy in the Newborn (RE-GLU)

Primary Purpose

Frenulum Breve

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Sugar and water solution
Sterile water
Sponsored by
IRCCS Burlo Garofolo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Frenulum Breve focused on measuring Ankyloglossia, Frenulotomy, water and sugar solution

Eligibility Criteria

1 Day - 10 Days (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  1. Term newborns (37 - 41 weeks of gestational age) within the first 10 days of life;
  2. Birth weight ≥ 2500 grams;
  3. Presence of ankyloglossia;
  4. Indication to the frenulotomy according to the Hazelbaker Assessment Tool for Lingual Frenulum Function (HATLFF): anatomical-functional evaluation with a score lower than 8.

Exclusion Criteria:

  1. Syndromic diagnosis (genetic/hereditary);
  2. Pathology of main organ (heart disease, brain disease etc.);
  3. Drugs intake that may interfere with the collected data (sedatives).

Sites / Locations

  • Institute for Maternal and Child Health - IRCCS Burlo Garofolo-Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Sugar and water solution

Sterile water

Arm Description

2 ml of a water and sugar solution (3 full-teaspoons of granulated sugar dissolved in half glass of water)

2 ml of sterile water

Outcomes

Primary Outcome Measures

Pain reduction
The perception of pain in newborns will be evaluated according to the Internationally Validated Neonatal Infant Pain Scale (NIPS).This scale detects the presence of six behavioral expression signs of neonatal pain (facial expression, crying, respiratory pattern, arms and legs' activity, arousal state) and ranges from 0 (absence of pain) to 7 (maximal pain level).

Secondary Outcome Measures

Pain reduction
The perception of pain in newborns will be evaluated according to the Internationally Validated Neonatal Infant Pain Scale (NIPS).This scale detects the presence of six behavioral expression signs of neonatal pain (facial expression, crying, respiratory pattern, arms and legs' activity, arousal state) and ranges from 0 (absence of pain) to 7 (maximal pain level).
Cortical oxy-haemoglobin change
Multichannel near-infrared spectroscopy will be used to estimate cerebral cortex activation by measuring increase in cortical oxy-haemoglobin (HbO2) (Hitachi multichannel NIRS system)

Full Information

First Posted
June 18, 2020
Last Updated
August 22, 2023
Sponsor
IRCCS Burlo Garofolo
search

1. Study Identification

Unique Protocol Identification Number
NCT04440462
Brief Title
Analgesia in Lingual Frenulotomy in the Newborn
Acronym
RE-GLU
Official Title
Lingual Frenulotomy in the Newborn: a Randomized Clinical Trial to Evaluate the Analgesic Effect of a Water and Sugar Solution in a Minor Surgical Procedure
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 18, 2020 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
IRCCS Burlo Garofolo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Ankyloglossia (tongue-tie) is a congenital anomaly characterized by a short lingual frenulum that limits the physiological tongue movement and occurs with an estimated prevalence between 4 and 10% of the newborns. This condition can be associated with difficulty in breastfeeding which can be painful for the mother, dysfunctional swallowing and future speech difficulties. The prevalence of nipple pain among women breastfeeding newborns with ankyloglossia is estimated to be between 36 and 80%. Since an early intervention can prevent the difficulties that may occur during the child's growth and can also improve the mothers and patients' quality of life, it is important to evaluate the lingual frenulum in the first days of life. The treatment of ankyloglossia consists in the frenulotomy which allows the release of the lingual frenulum and is a relatively simple procedure with few side effects and minimal post-operative. Different methods performed with or without local anaesthesia by means of scissors, blade, laser (etc.) are described in literature for the procedure the newborn. The hypothesis of the study is that the addition of a water and sugar solution to the standard analgesia with lidocaine may lead to a greater benefit in terms of pain control and determine the activation of different brain areas. The primary aim of the study is to evaluate whether the administration of a water and sugar solution to newborns undergoing frenulotomy receiving topical lidocaine as standard analgesic protocol, may lead to an additional benefit in terms of pain reduction evaluated according to the Neonatal Infant Pain Scale (NIPS). The secondary aim of the study is to evaluate through a Hitachi multichannel near-infrared spectroscopy (NIRS) the effects of the addition of a water and sugar solution to the standard analgesic protocol with topical lidocaine on the cortical activation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frenulum Breve
Keywords
Ankyloglossia, Frenulotomy, water and sugar solution

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
72 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sugar and water solution
Arm Type
Experimental
Arm Description
2 ml of a water and sugar solution (3 full-teaspoons of granulated sugar dissolved in half glass of water)
Arm Title
Sterile water
Arm Type
Active Comparator
Arm Description
2 ml of sterile water
Intervention Type
Other
Intervention Name(s)
Sugar and water solution
Intervention Description
2 ml of a water and sugar solution (3 full-teaspoons of granulated sugar dissolved in half glass of water)
Intervention Type
Other
Intervention Name(s)
Sterile water
Intervention Description
2 ml of sterile water
Primary Outcome Measure Information:
Title
Pain reduction
Description
The perception of pain in newborns will be evaluated according to the Internationally Validated Neonatal Infant Pain Scale (NIPS).This scale detects the presence of six behavioral expression signs of neonatal pain (facial expression, crying, respiratory pattern, arms and legs' activity, arousal state) and ranges from 0 (absence of pain) to 7 (maximal pain level).
Time Frame
30 seconds after the frenulotomy
Secondary Outcome Measure Information:
Title
Pain reduction
Description
The perception of pain in newborns will be evaluated according to the Internationally Validated Neonatal Infant Pain Scale (NIPS).This scale detects the presence of six behavioral expression signs of neonatal pain (facial expression, crying, respiratory pattern, arms and legs' activity, arousal state) and ranges from 0 (absence of pain) to 7 (maximal pain level).
Time Frame
During the frenulotomy
Title
Cortical oxy-haemoglobin change
Description
Multichannel near-infrared spectroscopy will be used to estimate cerebral cortex activation by measuring increase in cortical oxy-haemoglobin (HbO2) (Hitachi multichannel NIRS system)
Time Frame
30 seconds after the frenulotomy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
10 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Term newborns (37 - 41 weeks of gestational age) within the first 10 days of life; Birth weight ≥ 2500 grams; Presence of ankyloglossia; Indication to the frenulotomy according to the Hazelbaker Assessment Tool for Lingual Frenulum Function (HATLFF): anatomical-functional evaluation with a score lower than 8. Exclusion Criteria: Syndromic diagnosis (genetic/hereditary); Pathology of main organ (heart disease, brain disease etc.); Drugs intake that may interfere with the collected data (sedatives).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Milena Cadenaro, DDS MSc PhD
Phone
+390403785675
Email
milena.cadenaro@burlo.trieste.it
First Name & Middle Initial & Last Name or Official Title & Degree
Chiara Navarra, DDS MSc PhD
Phone
+390403785675
Email
chiara.navarra@burlo.trieste.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maddalena Chermetz, DDS MSc
Organizational Affiliation
Institute for maternal and child health Burlo Garofolo
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Milena Cadenaro, DDS MSc PhD
Organizational Affiliation
Institute for maternal and child health Burlo Garofolo
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Chiara Navarra, DDS MSc PhD
Organizational Affiliation
Institute for maternal and child health Burlo Garofolo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute for Maternal and Child Health - IRCCS Burlo Garofolo-
City
Trieste
ZIP/Postal Code
34137
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Milena Cadenaro
Email
milena.cadenaro@burlo.trieste.it

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Analgesia in Lingual Frenulotomy in the Newborn

We'll reach out to this number within 24 hrs